BFRIW
Income statement / Annual
Last year (2024), Biofrontera Inc.'s total revenue was $37.30 M,
an increase of 9.49% from the previous year.
In 2024, Biofrontera Inc.'s net income was -$17.76 M.
See Biofrontera Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$37.30 M |
$34.07 M |
$28.67 M |
$24.10 M |
$18.85 M |
$26.18 M |
| Cost of Revenue |
$18.61 M
|
$17.44 M
|
$15.19 M
|
$12.74 M
|
$9.07 M
|
$12.41 M
|
| Gross Profit |
$18.70 M
|
$16.63 M
|
$13.49 M
|
$11.36 M
|
$9.78 M
|
$13.77 M
|
| Gross Profit Ratio |
0.5
|
0.49
|
0.47
|
0.47
|
0.52
|
0.53
|
| Research and Development Expenses |
$2.09 M
|
$77,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$37.70 M
|
$35.87 M
|
$37.21 M
|
$18.12 M
|
$28.70 M
|
| Selling & Marketing Expenses |
$0.00
|
$1.43 M
|
$100,000.00
|
$500,000.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$33.84 M
|
$39.13 M
|
$35.87 M
|
$37.21 M
|
$18.12 M
|
$28.70 M
|
| Other Expenses |
$0.00
|
$100,000.00
|
$33,000.00
|
$689,000.00
|
$1.25 M
|
$5.48 M
|
| Operating Expenses |
$35.92 M
|
$39.30 M
|
$35.87 M
|
$37.21 M
|
$18.12 M
|
$28.70 M
|
| Cost And Expenses |
$54.53 M
|
$56.75 M
|
$51.06 M
|
$49.95 M
|
$27.18 M
|
$41.10 M
|
| Interest Income |
$30,000.00
|
$132,000.00
|
$175,000.00
|
$16,000.00
|
$28,000.00
|
$25,000.00
|
| Interest Expense |
$2.11 M
|
$600,000.00
|
$195,000.00
|
$344,000.00
|
$2.90 M
|
$2.16 M
|
| Depreciation & Amortization |
$1.15 M
|
$1.06 M
|
$1.17 M
|
$540,000.00
|
$562,000.00
|
$667,000.00
|
| EBITDA |
-$14.44 M |
-$18.45 M |
$934,000.00 |
-$36.76 M |
-$7.49 M |
-$8.15 M |
| EBITDA Ratio |
-0.39
|
-0.54
|
0.03
|
-1.53
|
-0.4
|
-0.31
|
| Operating Income Ratio |
-0.46
|
-0.67
|
-0.78
|
-1.07
|
-0.44
|
-0.57
|
| Total Other Income/Expenses Net |
-$527,000.00
|
$2.56 M
|
$17.97 M
|
-$12.46 M
|
-$2.59 M
|
$3.97 M
|
| Income Before Tax |
-$17.74 M
|
-$20.12 M
|
-$608,000.00
|
-$37.66 M
|
-$10.92 M
|
-$10.95 M
|
| Income Before Tax Ratio |
-0.48
|
-0.59
|
-0.02
|
-1.56
|
-0.58
|
-0.42
|
| Income Tax Expense |
$22,000.00
|
$14,000.00
|
$32,000.00
|
$56,000.00
|
$64,000.00
|
$33,000.00
|
| Net Income |
-$17.76 M
|
-$20.13 M
|
-$640,000.00
|
-$37.71 M
|
-$10.99 M
|
-$10.98 M
|
| Net Income Ratio |
-0.48
|
-0.59
|
-0.02
|
-1.56
|
-0.58
|
-0.42
|
| EPS |
-0.0032 |
-13.02 |
-0.61 |
-44.1 |
-18.94 |
-18.09 |
| EPS Diluted |
-0.0032 |
-13.02 |
-0.61 |
-44.1 |
-18.94 |
-18.09 |
| Weighted Average Shares Out |
$5.52 B
|
$1.55 B
|
$1.06 B
|
$855.24 M
|
$580.00 M
|
$607.00 M
|
| Weighted Average Shares Out Diluted |
$5.52 B
|
$1.55 B
|
$1.06 B
|
$855.24 M
|
$580.00 M
|
$607.00 M
|
| Link |
|
|
|
|
|
|
